Role of in vitro metabolic interactions in the conduct of drug-drug interaction (DDI) studies.

被引：0
|
作者：
Yuan, R [1 ]
Balian, JD [1 ]
Svadjian, R [1 ]
Uppoor, RS [1 ]
Ajayi, F [1 ]
Burnett, A [1 ]
Lesko, LJ [1 ]
Marroum, P [1 ]
机构：
[1] US FDA, Ctr Drug Evaluat & Res, Off Clin Pharmacol & Biopharm, Rockville, MD 20857 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1998年 / 63卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PIII46
引用
收藏
页码：218 / 218
页数：1
相关论文
共 50 条
  • [31] A study of pharmacist antiretroviral stewardship in relation to drug-drug interaction (DDI) checking
    Heekin, A.
    Barbosa, T.
    Moriarty, M.
    Coghlan, M.
    Bergin, C.
    HIV MEDICINE, 2023, 24 : 307 - 308
  • [32] Predicting drug-drug interactions:: In vitro veritas?
    Tucker, GT
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 23 : S13 - S13
  • [33] A Review of CYP-Mediated Drug Interactions: Mechanisms and In Vitro Drug-Drug Interaction Assessment
    Lee, Jonghwa
    Beers, Jessica L.
    Geffert, Raeanne M.
    Jackson, Klarissa D.
    BIOMOLECULES, 2024, 14 (01)
  • [34] Inhibition-based metabolic drug-drug interactions:: Predictions from in vitro data
    Yao, CP
    Levy, RH
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2002, 91 (09) : 1923 - 1935
  • [35] TP-DDI: Transformer-based pipeline for the extraction of Drug-Drug Interactions
    Zaikis, Dimitrios
    Vlahavas, Ioannis
    ARTIFICIAL INTELLIGENCE IN MEDICINE, 2021, 119
  • [36] CNN-DDI: A novel deep learning method for predicting drug-drug interactions
    Zhang, Chengcheng
    Zang, Tianyi
    2020 IEEE INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND BIOMEDICINE, 2020, : 1708 - 1713
  • [37] Polypharmacy in hematology and oncology patients and the resulting prevalence of potential drug-drug interactions (DDI)
    Metzke, B.
    Fink, G.
    Hieke, S.
    Jung, M.
    Hug, M. J.
    Engelhardt, M.
    ONKOLOGIE, 2012, 35 : 76 - 76
  • [38] In vitro evidence for the role of OATP and OCT uptake transporters in drug-drug interactions
    Kindla, Juergen
    Fromm, Martin F.
    Koenig, Joerg
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2009, 5 (05) : 489 - 500
  • [39] THE EFFECT OF DEUTERATION OF VX-509 (DECERNOTINIB) ON DRUG-DRUG INTERACTIONS (DDI) WITH MIDAZOLAM
    Huang, J.
    Yang, F.
    Yogaratnam, J.
    Shen, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 740 - 740
  • [40] Metabolic drug-drug interactions of the azole antifungai drugs
    Billaud, Eliane M.
    JOURNAL DE MYCOLOGIE MEDICALE, 2007, 17 (03): : 168 - 176
12345